Menu
Not yet recruiting NCT06797700

Risk Factors of Paraspinal Muscles in Degenerative Lumbar Spondylolisthesis

Observational Spine Degeneration

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Spine Degeneration. Basic parameters: 50 years — 80 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Prediction of Risk Factors of Paraspinal Muscles in Degenerative Lumbar Spondylolisthesis Based on Spine MRI

Overview

This is a retrospectively observational study. The goal of this observational study is to analyze the risk factors of paraspinal muscles associated with the occurrence of spondylolisthesis in patients with degenerative lumbar spondylolisthesis(DLS) and to construct a predictive model. The main question it aims to answer is: Which paraspinal muscle changes are risk factors for DLS? We will collect the information of patients who have undergone lumbar MRI in our hospital and have been diagnosed with back pain ( including spondylolisthesis or no spondylolisthesis) during the period from 2022 to 2024.The collected data included gender, age, body mass index (BMI), diabetes, hypertension, occupation and imaging parameters. We will then retrospectively analyze the risk factors associated with lumbar spondylolisthesis.

Primary outcome measures

  • the MF FCSA [Time frame: Two weeks before treatment]
  • the ES FCSA [Time frame: Two weeks before treatment]
  • the MF CSA [Time frame: Two weeks before treatment]
  • the ES CSA [Time frame: Two weeks before treatment]
Secondary outcome measures (1)
  • SMI [Time frame: Two weeks before treatment]

Eligibility criteria

Inclusion criteria

  • Patients who presented to our hospital with back pain(the diagnosis was spondylolisthesis or no spondylolisthesis);
  • Patients older than 50 years;
  • Patients with complete clinical data and magnetic resonance imaging (MRI) before surgery.

Exclusion criteria

  • The patient has previous spinal surgery;
  • Patients with lumbar tumor,lumbar infection and lumbar tuberculosis;
  • Patients with incomplete MRI sequence.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Other

Study locations

China · 1 center
  • The First People's Hospital of Yunnan — Kunming

Identifiers

NCT: NCT06797700 · KHLL2025-KY047 · 2024JSKFKT-17

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗